Skip to main content
SpringerLink
Log in

Endocrine function in uremia

  • Chapter
Replacement of Renal Function by Dialysis

  • 576 Accesses

Abstract

For decades the lethargy, anorexia, lowered basal temperature, gynecomastia, amenorrhea, osteodystrophy, neuropathy, impaired cognition, growth retardation, anemia, hypertension, hyperlipidemia, and glucose intolerance of chronic renal insufficiency (CRI) and uremia have been ascribed to endocrine dysfunction and metabolic intoxication. Subsequently, sensitive quantitative methods have been applied to investigate the endocrine and metabolic function of uremia, and it appears that the kidneys play a pivotal role in endocrine regulation. There are at least eight patterns of endocrine dysfunction attributable to advanced renal disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Drüeke TB. Parathyroid gland hyperplasia in uremia. Kidney Int. 2001;59:1182–3.

    Article  PubMed  Google Scholar 

  2. Silver J, Yalcindag C, Sela-Brown A, Kilav R, Naveh Many T. Regulation of the parathyroid hormone gene by vitamin D, calcium and phosphate. Kidney Int. 1999; 56(Suppl. 73):S2–7.

    Article  Google Scholar 

  3. Vaziri ND. Effect of chronic renal failure on nitric oxide metabolism. Am J Kidney Dis. 2001;38(Suppl. 1):S74–9.

    Article  Google Scholar 

  4. Kleger GR, Turgay M, Imoberdorf R, McNurlan MA, Garlick PJ, Ballmer PE. Acute metabolic acidosis decreases muscle protein synthesis but not albumin synthesis in humans. Am J Kidney Dis. 2001;38:1199–207.

    Article  PubMed  CAS  Google Scholar 

  5. Plotkin E, Golan E, Shimoni T, Korzets Z. Stupor and flaccid paralysis in a patient with end-stage renal failure. Nephrol Dial Transplant. 2002;17:159–60.

    Article  PubMed  Google Scholar 

  6. Jackson MA, Holland MR, Nicholas J et al. Occult hypoglycemia caused by hemodialysis. Clin Nephrol. 1999; 51:242–7.

    PubMed  CAS  Google Scholar 

  7. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int. 1998;53:1068–77.

    Article  PubMed  CAS  Google Scholar 

  8. Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG. Sympathetic overactivity as a cause of hypertension in chronic renal failure. J Hypertens. 2002;20:3–9.

    Article  PubMed  CAS  Google Scholar 

  9. Ritz E, Koomans HA. New insights into mechanisms of blood pressure regulation in patients with uraemia. Nephrol Dial Transplant. 1996;11 (Suppl. 2):52–9.

    Article  PubMed  Google Scholar 

  10. Hörl MP, Hörl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002; 39:227–44.

    Article  PubMed  Google Scholar 

  11. Diez JJ, Iglesias P, Selgas R, Bajo MA, Aguilera A. Cholinergic modulation of growth hormone responses to growth hormone-releasing hormone in uraemic patients on peritoneal dialysis. Clin Endocrinol. 2000;53:587–93.

    Article  CAS  Google Scholar 

  12. Jungers P. Late referral: loss of chance for the patient, loss of money for society. Nephrol Dial Transplant. 2002;17: 371–5.

    Article  PubMed  Google Scholar 

  13. Eschbach JW. The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int. 1989;35:134–48.

    Article  PubMed  CAS  Google Scholar 

  14. Ridley DM, Dawkins F, Perlin E. Erythropoietin: a review. J Natl Med Assoc. 1994;86:129–35.

    PubMed  CAS  Google Scholar 

  15. Evans RW, Rader B, Manninen DL. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. J Am Med Assoc. 1990;263: 825–30.

    Article  CAS  Google Scholar 

  16. Anonymous. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group. Br Med J. 1990;300:573–8.

    Article  Google Scholar 

  17. Mann JF. What are the short-term and long-term consequences of anaemia in CRF patients? Nephrol Dial Transplant. 1999;14 (Suppl. 2):29–36.

    Article  PubMed  Google Scholar 

  18. Collins AJ, Li S, St Peter W et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol. 2001;12:2465–73.

    PubMed  CAS  Google Scholar 

  19. Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J. Erythropoietin and sexual dysfunction. Nephrol Dial Transplant. 1997;12:741–7.

    Article  PubMed  CAS  Google Scholar 

  20. Tokgoz B, Utas C, Dogukan A et al. Effects of long-tern erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients. Pert Dial Int. 2001; 21:448–54.

    CAS  Google Scholar 

  21. Diez JJ, Iglesias P, Sastre J et al. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis. Metabolism. 1999;48:210–16.

    Article  PubMed  CAS  Google Scholar 

  22. Mak RH. Metabolic effects of erythropoietin in patients on peritoneal dialysis. Pediatr Nephrol. 1998;12:660–5.

    Article  PubMed  CAS  Google Scholar 

  23. Sherrard DJ, Hercz G, Pei Y et al. The spectrum of bone disease in end-stage renal failure — an evolving disorder. Kidney Int. 1993;43:436–42.

    Article  PubMed  CAS  Google Scholar 

  24. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am J Kidney Dis. 2000;36:1115–21.

    Article  PubMed  CAS  Google Scholar 

  25. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T. Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis. 1999;33:287–97.

    Article  PubMed  CAS  Google Scholar 

  26. Drüeke TB. 32-Microglobulin and amyloidosis. Nephrol Dial Transplant. 2000;15:17–24.

    Google Scholar 

  27. Coburn J, Llach F. Renal osteodystrophy and maintenance dialysis. In: Drukker W, Parsons FM, Maher JF, editors. Replacement of Renal Function by Dialysis. The Hague: Martinus Nijhoff, 1978:571–600.

    Google Scholar 

  28. Monier-Faugere MC, Geng Z, Mawad H et al. Improved assessment of bone turnover by the PTH-(1–84)/large C-PTH fragments ratio in ESRD patients. Kidney Int. 2001;60: 1460–8.

    Article  PubMed  CAS  Google Scholar 

  29. Slatopolsky E, Finch J, Clay P et al. Novel mechanism for skeletal resistance in uremia. Kidney Int. 2000;58:753–61.

    PubMed  CAS  Google Scholar 

  30. Hoyland JA, Picton ML. Cellular mechanisms of renal osteodystrophy. Kidney Int. 1999;56 (Suppl. 73):S8–13.

    Article  Google Scholar 

  31. Ramírez G, Jubiz W, Gutch CF, Bloomer HA, Siegler R, Kolff WJ. Thyroid abnormalities in renal failure. A study of 53 patients on chronic hemodialysis. Ann Intern Med. 1973; 79:500–4.

    Article  PubMed  Google Scholar 

  32. Duntas L, Wolf CF, Keck FS, Rosenthal J. Thyrotropinreleasing hormone: pharmacokinetic and pharmacodynamic properties in chronic renal failure. Clin Nephrol. 1992; 38:214–18.

    PubMed  CAS  Google Scholar 

  33. Lim VS. Thyroid function in patients with chronic renal failure. Am J Kidney Dis. 2001;38(Suppl. 1):580–4.

    Article  Google Scholar 

  34. Lim VS, Fang VS, Katz AI, Refetoff S. Thyroid dysfunction in chronic renal failure. A study of the pituitary-thyroid axis and peripheral turnover kinetics of thyroxine and triiodothyronine. J Clin Invest. 1977;60:522–34.

    Article  PubMed  CAS  Google Scholar 

  35. Lim VS, Henriquez C, Seo H, Refetoff S, Martino E. Thyroid function in a uremic rat model. Evidence suggesting tissue hypothyroidism. J Clin Invest. 1980;66: 946–54.

    Article  PubMed  CAS  Google Scholar 

  36. Lim VS, Passo C, Murata Y, Ferrari E, Nakamura H, Refetoff S. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only. Endocrinology. 1984;114:280–6.

    Article  PubMed  CAS  Google Scholar 

  37. Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Rev. 1996;17: 45–63.

    CAS  Google Scholar 

  38. Ooi DS, Mahadevan MS, Greenway DC, Gertler SZ. Evaluation of four commercially available assays for free thyroxin. Clin Chem. 1988;34:2302–7.

    PubMed  CAS  Google Scholar 

  39. Midgley JEM, Sheehan CP, Christofides ND, Fry JE, Browning D, Mardell R. Concentrations of free thyroxin and albumin in serum in severe nonthyroidal illness: assay artefacts and physiological influences. Clin Chem. 1990;36: 765–71.

    PubMed  CAS  Google Scholar 

  40. Yonemura K, Nakajima T, Suzuki T et al. Low free thyroxine concentrations and deficient nocturnal surge of thyroid-stimulating hormone in haemodialysed patients compared with undialysed patients Nephrol Dial Transplant. 2000;15:668–72.

    CAS  Google Scholar 

  41. De Groot LJ. Dangerous dogmas in medicine: the nonthyroidal illness syndrome. J Clin Endocrinol Metab. 1999;84:151–64.

    Article  PubMed  Google Scholar 

  42. Boelen A, Platvoetter Schiphorst MC, Wiersinga WM. Soluble cytokine receptors and the low 3,5,3 ′-triiodothyronine syndrome in patients with nonthyroidal disease. J Clin Endocrinol Metab. 1995;80:971–6.

    Article  PubMed  CAS  Google Scholar 

  43. Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol. 1996;7:2646–53.

    PubMed  CAS  Google Scholar 

  44. Kuhlmann U, Schwickardi M, Trebst R, Lange H. Resting metabolic rate in chronic renal failure. J Renal Nutr. 2001;11:202–6.

    Article  CAS  Google Scholar 

  45. Lim VS, Zavala DC, Flanigan MJ, Freeman RM. Blunted peripheral tissue responsiveness to thyroid hormone in uremic patients. Kidney Int. 1987;31:808–14.

    Article  PubMed  CAS  Google Scholar 

  46. Brungger M, Hulter HN, Krapf R. Effect of chronic metabolic acidosis on thyroid hormone homeostasis in humans. Am J Physiol. 1997;272:F648–53.

    Google Scholar 

  47. Ramirez G, Bittle PA, Sanders H, Bercu BB. Hypothalamohypophyseal thyroid and gonadal function before and after erythropoietin therapy in dialysis patients. J Clin Endocrinol Metab. 1992;74:517–24.

    Article  PubMed  CAS  Google Scholar 

  48. Utas C, Taskapan H, Oymak O, Akpolat T, Arinsoy T, Kelestimur F. Improvement of thyroid hormone profile and thyrotrophin (TSH) surge alterations in hemodialysis patients on erythropoietin treatment. Clin Nephrol. 2001;55:471–6.

    PubMed  CAS  Google Scholar 

  49. Whitworth JA, Stewart PM, Burt D, Atherden SM, Edwards CR. The kidney is the major site of cortisone production in man. Clin Endocrinol. 1989;31:355.

    Article  CAS  Google Scholar 

  50. Albiston AL, Obeyesekere VR, Smith RE, Krozowski ZS. Cloning and tissue distribution of the human 11 betahydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol. 1994;105:R11–17.

    Article  Google Scholar 

  51. Edwards CR, Stewart PM, Burt D et al. Localisation of 11 beta-hydroxysteroid dehydrogenase — tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2: 986–9.

    Article  PubMed  CAS  Google Scholar 

  52. McDonald WJ, Golper TA, Mass RD et al. Adrenocorticotropin-cortisol axis abnormalities in hemodialysis patients. J Clin Endocrinol Metab. 1979;48:92–5.

    Article  PubMed  CAS  Google Scholar 

  53. Nolan GE, Smith JB, Chavre VJ, Jubiz W. Spurious overestimation of plasma cortisol in patients with chronic renal failure. J Clin Endocrinol Metab. 1981;52:1242–5.

    Article  PubMed  CAS  Google Scholar 

  54. Clodi M, Riedl M, Schmaldienst S et al. Adrenal function in patients with chronic renal failure. Am J Kidney Dis. 1998;32:52–5.

    Article  PubMed  CAS  Google Scholar 

  55. Vigna L, Buccianti G, Orsatti A et al. The impact of longterm hemodialysis on pituitary-adrenocortical function. Renal Failure. 1995;17:629–37.

    Article  PubMed  CAS  Google Scholar 

  56. Mishkin MS, Hsu JH, Walker WG, Bledsoe T. Studies on the episodic secretion of cortisol in uremic patients on hemodialysis. Johns Hopkins Med J. 1972;131:160–4.

    PubMed  CAS  Google Scholar 

  57. N’Gankam V, Uehlinger D, Dick B, Frey BM, Frey FJ. Increased cortisol metabolites and reduced activity of 11β-hydroxysteroid dehydrogenase in patients on hemodialysis. Kidney Int. 2002;61:1859–66.

    Article  PubMed  Google Scholar 

  58. Lovati E, Ferrari P, Dick B et al. Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab. 1999;84:3745–9.

    Article  PubMed  CAS  Google Scholar 

  59. Letizia C, Mazzaferro S, De Ciocchis A et al. Effects of haemodialysis session on plasma beta-endorphin, ACTH and cortisol in patients with end-stage renal disease. Scand J Urol Nephrol. 1996;30:399–402.

    Article  PubMed  CAS  Google Scholar 

  60. Ramirez G, Gomez-Sanchez C, Meikle WA, Jubiz W. Evaluation of the hypothalamic hypophyseal adrenal axis in patients receiving long-term hemodialysis. Arch Intern Med. 1982;142:1448–52.

    Article  PubMed  CAS  Google Scholar 

  61. Zarif L, Newman L, Tessman M et al. Cortisol kinetics and dexamethasone suppression test in peritoneal dialysis patients. Pert Dial Int. 1998;18 (Suppl. 1):S45.

    Google Scholar 

  62. Cushing ’s syndrome. spivnIn: Ravel R, editor. Clinical Laboratory Medicine, 6th edn. St Louis, MO: Mosby-Year Book, 1995:509.

    Google Scholar 

  63. Orth DN, Kovacs WJ. The adrenal cortex. In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P, editors. Williams Textbook of Endocrinology, 9th edn. Philadelphia, PA: W. B. Saunders, 1998:580–2.

    Google Scholar 

  64. Rosman PM, Farag A, Peckham R et al. Pituitary-adrenocortical function in chronic renal failure: blunted suppression and early escape of plasma cortisol levels after intravenous dexamethasone. J Clin Endocrinol Metab. 1982;54:528–33.

    Article  PubMed  CAS  Google Scholar 

  65. Van Herle AJ, Birnbaum JA, Slomowitz LA et al. Paper chromatography prior to cortisol RIA allows for accurate use of the dexamethasone suppression test in chronic renal failure. Nephron. 1998;80:79–84.

    Article  PubMed  Google Scholar 

  66. Roberts NB, Dutton J, McClelland P, Bone JM. Urinary catecholamine excretion in relation to renal function. Ann Clin Biochem. 1999;36:587–91.

    PubMed  CAS  Google Scholar 

  67. Uusimaa P, Huttunen K, Ruskoaho H, Linnaluoto M, Ikaheimo M. Neurohumoral responses to a single haemodialysis in chronic renal patients. Acta Physiol Scand. 1999;165:25–31.

    Article  PubMed  CAS  Google Scholar 

  68. Dutton J, Hodgkinson AJ, Hutchinson G, Roberts NB. Evaluation of a new method for the analysis of free catecholamines in plasma using automated sample trace enrichment with dialysis and HPLC. Clin Chem. 1999;45:394–9.

    PubMed  CAS  Google Scholar 

  69. Godfrey JA, Rickman OB, Williams AW, Thompson GB, Young WF. Pheochromocytoma in a patient with end-stage renal disease. Mayo Clin Proc. 2001;76:953–7.

    PubMed  CAS  Google Scholar 

  70. Asaka S, Takayama Y, Tagawa S et al. Pheochromocytoma in a long-term hemodialysis patient, discovered as an adrenal incidentaloma. Intern Med. 1997;36:403–7.

    Article  PubMed  CAS  Google Scholar 

  71. Korenman SG. Sexual function and dysfunction. In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P, editors. Williams Textbook of Endocrinology, 9th edn. Philadelphia, PA: W. B. Saunders, 1998:927–38.

    Google Scholar 

  72. Yamamoto Y, Sofikitis N, Miyagawa I. Effects of chronic renal failure on hypothalamo-pituitary-testicular axis function and fertility in rats. Int J Urol. 1996;3:484–90.

    Article  PubMed  CAS  Google Scholar 

  73. Caticha O, Norato DY, Tambascia MA, Santana A, Stephanou A, Sarlis NJ. Total body zinc depletion and its relationship to the development of hyperprolactinemia in chronic renal insufficiency. J Endocrinol Invest. 1996; 19:441–8.

    PubMed  CAS  Google Scholar 

  74. Wu SC, Lin SL, Jeng FR. Influence of erythropoietin treatment on gonadotropic hormone levels and sexual function in male uremic patients. Scand J Urol Nephrol. 2001;35:136–40.

    Article  PubMed  CAS  Google Scholar 

  75. Schaefer F, van Kaick B, Veldhuis JD et al. Changes in the kinetics and biopotency of luteinizing hormone in hemodialyzed men during treatment with recombinant human erythropoietin. J Am Soc Nephrol. 1994;5:1208–15.

    PubMed  CAS  Google Scholar 

  76. Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J. Erythropoietin and sexual dysfunction. Nephrol Dial Transplant. 1997;12:741–7.

    Article  PubMed  CAS  Google Scholar 

  77. Rosas SE, Joffe M, Franklin E et al. Prevalence and determinants of erectile dysfunction in hemodialysis patients. Kidney Int. 2001;59:2259–66.

    PubMed  CAS  Google Scholar 

  78. Turk S, Karalezli G, Tonbul HZ et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2001;16:1818–22.

    Article  PubMed  CAS  Google Scholar 

  79. Lawrence IG, Price DE, Howlett TA, Harris KP, Feehally J, Walls J. Correcting impotence in the male dialysis patient: experience with testosterone replacement and vacuum tumescence therapy. Am J Kidney Dis. 1998;31:313–19.

    Article  PubMed  CAS  Google Scholar 

  80. Kawashima R, Douchi T, Oki T, Yoshinaga M, Nagata Y. Menstrual disorders in patients undergoing chronic hemodialysis. J Obstet Gynaecol Res. 1998;24:367–73.

    Article  PubMed  CAS  Google Scholar 

  81. Lim VS, Flanigan MJ. Abnormal endocrine function in chronic renal failure. In: Jacobs C, Kjellstrand CM, Koch KM, Winchester JF, editors. Replacement of Renal Function by Dialysis, 4th edn. Dordrecht: Kluwer, 1995: 1236–42.

    Google Scholar 

  82. Schmidt A, Luger A, Horl WH. Sexual hormone abnormalities in male patients with renal failure. Nephrol Dial Transplant. 2002;17:368–71.

    Article  PubMed  CAS  Google Scholar 

  83. Hou S. Pregnancy in chronic renal insufficiency and endstage renal disease. Am J Kidney Dis. 1999;33:235–52.

    Article  PubMed  CAS  Google Scholar 

  84. Veldhuis JD, Wilkowski MJ, Zwart AD et al. Evidence for attenuation of hypothalamic releasing hormone (GnRH) impulse strength with preservation of GnRH pulse frequency in men with chronic renal failure. J Clin Endocrinol Metab. 1993;76:648–54.

    Article  PubMed  CAS  Google Scholar 

  85. Reichlin S. Neuroendocrinology In: Wilson JD, Foster DW, Kronenberg HM, Reed Larsen P, editors. Williams Textbook of Endocrinology, 9th edn. Philadelphia, PA: W. B. Saunders, 1998:165–248.

    Google Scholar 

  86. Schaefer F, Vogel M, Kerkhoff G, Woitzik J, Daschner M, Mehls O. Experimental uremia affects hypothalamic amino acid neurotransmitter milieu. J Am Soc Nephrol. 2001;12:1218–27.

    PubMed  CAS  Google Scholar 

  87. Diez JJ, Iglesias P, Aguilera A, Bajo MA, Selgas R. Effects of cholinergic muscarinic blockade on growth hormone responses to growth hormone-releasing hormone in uraemic patients. Nephrol Dial Transplant. 1999;14:1704–9.

    Article  PubMed  CAS  Google Scholar 

  88. Diez J, Iglesias P, Sastre J, Mendez J, Selgas R, Gomez-Pan A. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients. Nephron. 1996;74:548–54.

    Article  PubMed  CAS  Google Scholar 

  89. Smogorzewski MJ. Central nervous dysfunction in uremia. Am J Kidney Dis. 2001;38 (Suppl. 1):S122–8.

    Article  Google Scholar 

  90. van den Berghe G, Weekers F, Baxter RC et al. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. J Clin Endocrinol Metab. 2001; 86:3217–26.

    Article  PubMed  Google Scholar 

  91. Williams NI, Helmreich DL, Parfitt DB, Caston-Balderrama A, Cameron JL. Evidence for a causal role of low energy availability in the induction of menstrual cycle disturbances during strenuous exercise training. J Clin Endocrinol Metab. 2001;86:5184–93.

    Article  PubMed  CAS  Google Scholar 

  92. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11:319–29.

    PubMed  CAS  Google Scholar 

  93. Neugarten J, Acharya A, Lei J, Silbiger S. Selective estrogen receptor modulators suppress mesangial cell collagen synthesis. Am J Physiol. 2000;279:F309–18.

    Google Scholar 

  94. Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U. Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. Kidney Int. 2001;60: 1955–63.

    Article  PubMed  CAS  Google Scholar 

  95. Stefoni S, Mosconi G, La Manna G et al. Low-dosage ibopamine treatment in progressive renal failure: a long-term multicentre trial. Am J Nephrol. 1996;16:489–99.

    Article  PubMed  CAS  Google Scholar 

  96. Spaia S, Pangalos M, Askepidis N et al. Effect of short-term rHuEPO treatment on insulin resistance in haemodialysis patients. Nephron. 2000;84:320–5.

    Article  PubMed  CAS  Google Scholar 

  97. Garibotto G, Barreca A, Sofia A et al. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition. J Am Soc Nephrol. 2000;11:2106–13.

    PubMed  CAS  Google Scholar 

  98. Bigner DR, Goff JP, Faust MA, Burton JL, Tyler HD, Horst RL. Acidosis effects on insulin response during glucose tolerance tests in Jersey cows. J Dairy Sci. 1996;79:2182–8.

    Article  PubMed  CAS  Google Scholar 

  99. Mak RH. Effect of metabolic acidosis on insulin action and secretion in uremia. Kidney Int. 1998;54:603–7.

    Article  PubMed  CAS  Google Scholar 

  100. Massry SG. Insulin secretion in uremia. Am J Kidney Dis. 2001;38 (Suppl. 1):S58–62.

    Article  Google Scholar 

  101. Castellino P, Luzi L, Giordano M, Defronzo RA. Effects of insulin and amino acids on glucose and leucine metabolism in CAPD patients. J Am Soc Nephrol. 1999;10:1050–8.

    PubMed  CAS  Google Scholar 

  102. Stenvinkel P, Lindholm B, Lonnqvist F, Katzarski K, Heimburger O. Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body mass. J Am Soc Nephrol. 2000;11: 1303–9.

    PubMed  CAS  Google Scholar 

  103. Stenvinkel P, Lonnqvist F, Schalling M. Molecular basis of renal disease. Molecular studies of leptin: implications for renal disease. Nephrol Dial Transplant. 1999;14:1103–12.

    Article  PubMed  CAS  Google Scholar 

  104. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis. 2002;39:1–11.

    Article  PubMed  CAS  Google Scholar 

  105. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue — a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002;17:191–5.

    Article  PubMed  Google Scholar 

  106. Garibotto G, Barreca A, Sofia A et al. Effects of growth hormone on leptin metabolism and energy expenditure in hemodialysis patients with protein-calorie malnutrition. J Am Soc Nephrol. 2000;11:2106–13.

    PubMed  CAS  Google Scholar 

  107. Haffner D, Wuhl E, Schaefer F, Nissel R, Tonshoff B, Mehls O. Factors predictive of the short- and long-term efficacy of growth hormone treatment in prepubertal children with chronic renal failure. The German study group for growth hormone treatment in chronic renal failure. J Am Soc Nephrol. 1998;9:1899–907.

    PubMed  CAS  Google Scholar 

  108. Hansen TB, Gram J, Jensen PB et al. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study. Clin Nephrol. 2000;53: 99–107.

    PubMed  CAS  Google Scholar 

  109. Fouque D, Peng Sc, Shamir E, Kopple JD. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients. Kidney Int. 2000;57:646–54.

    PubMed  CAS  Google Scholar 

  110. Szabo A, Kenesei E, Tulassay T, Sallay P, Szucs L, Nagy I. Plasma amino acid concentration under human growth hormone treatment in uremic children. Hormone Res. 1995;44:265–7.

    Article  PubMed  CAS  Google Scholar 

  111. Tonshoff B, Veldhuis JD, Heinrich U, Mehls O. Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res. 1995:37:86–93.

    Article  PubMed  CAS  Google Scholar 

  112. Muller EE, Rolla M, Ghigo E et al. Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications. Drugs. 1995;50:805–37.

    Article  PubMed  CAS  Google Scholar 

  113. Bircan Z, Kervancioglu M, Soran M, Yildirim I. Growth hormone stimulation tests in chronic renal failure with metabolic acidosis. Acta Paediatr Jpn. 1998;40:70–2.

    Article  PubMed  CAS  Google Scholar 

  114. Green J, Maor G. Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int. 2000;57:2258–67.

    Article  PubMed  CAS  Google Scholar 

  115. Roelfsema V, Clark RG. The growth hormone and insulinlike growth factor axis: Its manipulation for the benefit of growth disorders in renal failure. J Am Soc Nephrol. 2001,12:1297–306.

    PubMed  CAS  Google Scholar 

  116. Frystyk J, Ivarsen P, Stoving RK et al. Determination of free insulin-like growth factor-I in human serum: comparison of ultrafiltration and direct immunoradiometric assay. Growth Horm IGF Res. 2001;11:117–27.

    Article  PubMed  CAS  Google Scholar 

  117. Van Doorn J, Ringeling AM, Shmueli SS et al. Circulating levels of human insulin-like growth factor binding protein-6 (IGFBP-6) in health and disease as determined by radioimmunoassay. Clin Endocrinol. 1999;50:601–9.

    Article  Google Scholar 

  118. Mak RH, Pak YK. End-organ resistance to growth hormone and IGF-I in epiphyseal chondrocytes of rats with chronic renal failure. Kidney Int. 1996;50:400–6.

    Article  PubMed  CAS  Google Scholar 

  119. Garcia E, Santos F, Rodriguez J, Martinez V, Rey C, Veldhuis J, Krieg RJ. Impaired secretion of growth hormone in experimental uremia: relevance of caloric deficiency. Kidney Int. 1997;52:648–53.

    Article  PubMed  CAS  Google Scholar 

  120. Ordonez FA, Santos F, Martinez V, Garcia E, Fernandez P, Rodriguez J. Resistance to growth hormone and insulin-like growth factor-I in acidotic rats. Pediatr Nephrol. 2000; 14:720–5.

    Article  PubMed  CAS  Google Scholar 

  121. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Juppner H, Goodman WG. Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int. 1998;54:1879–87.

    Article  PubMed  CAS  Google Scholar 

  122. Fischbach M, Terzic J, Menouer S, Provot E, Laugel V. Normal statural growth in 2 infants on chronic peritoneal dialysis: anecdotal or whole management-related. Clin Nephrol. 2001;56:S17–20.

    Google Scholar 

  123. Tom A, McCauley L, Bell L et al. Growth during maintenance hemodialysis: impact of enhanced nutrition and clearance. J Pediatr. 1999;134:464–71.

    Article  PubMed  CAS  Google Scholar 

  124. Vallance P. Importance of asymmetrical dimethylarginine in cardiovascular risk. Lancet. 2001;358:2096–7.

    Article  PubMed  CAS  Google Scholar 

  125. Zoccali C, Bode-Boger SM, Mallamaci F et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet. 2001;358:2113–17.

    Article  PubMed  CAS  Google Scholar 

  126. Schaefer F, Vogel M, Kerkhoff G, Woitzik J, Daschner M, Mehls O. Experimental uremia affects hypothalamic amino acid neurotransmitter milieu. J Am Soc Nephrol. 2001;12:1218–27.

    PubMed  CAS  Google Scholar 

  127. Tabakian A, Juillard L, Laville M, Joly MO, Laville M, Fouque D. Effects of recombinant growth factors on energy expenditure in maintenance hemodialysis patients. Miner Electrolyte Metab. 1998;24:273–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Michael J. Flanigan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victoria Sy Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Nephrology, Department of Medicine III, University of Vienna, Währinger Gurtel 18-20, A-1090, Vienna, Austria

    Walter H. Hörl

  2. Division of Nephrology, Centre for Internal Medicine and Dermatology, Medizinische Hochschule, Hannover, Germany

    Karl M. Koch

  3. Optimal Dialysis Research Unit, London Health Sciences Centre and The University of Western Ontario, London, Ontario, Canada

    Robert M. Lindsay

  4. Department of Nephrology, St. Bortolo Hospital, Viale Rodolfi, I-36100, Vicenza, Italy

    Claudio Ronco

  5. RenalTech International, LLC, 320 East 65th St, #116, New York, NY, 10021, USA

    James F. Winchester

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Flanigan, M.J., Lim, V.S. (2004). Endocrine function in uremia. In: Hörl, W.H., Koch, K.M., Lindsay, R.M., Ronco, C., Winchester, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-2275-3_42

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-2275-3_42

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-015-7012-1

  • Online ISBN: 978-1-4020-2275-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation